Name: | Regeneron Pharmaceuticals, Inc. |
Jurisdiction: | MISSISSIPPI |
Business Type: | Profit Corporation |
Status: | Good Standing |
Effective Date: | 20 Oct 2011 (14 years ago) |
Branch of: | Regeneron Pharmaceuticals, Inc., NEW YORK (Company Number 1226128) |
Business ID: | 990708 |
State of Incorporation: | NEW YORK |
Principal Office Address: | 777 Old Saw Mill River Road Tarrytown, NY 10591 |
Name | Role | Address |
---|---|---|
C T CORPORATION SYSTEM | Agent | 645 LAKELAND EAST DRIVE, Suite 101, FLOWOOD, MS 39232 |
Name | Role | Address |
---|---|---|
Ph.D. Leonard S. Schleifer MD | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Ph.D Bonnie L. Bassler | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
M.D Michael S. Brown | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
M.D. Anthony N Coles | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
M.D. Joseph L. Goldstein | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Christine A. Poon | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Arthur F. Ryan | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
George L. Sing | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Ph.D. Marc Tessier-Lavigne | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
M.D.P. Roy Vagelos | Director | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Name | Role | Address |
---|---|---|
Ph.D. Leonard S. Schleifer MD | President | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
M.D,PhD.George D. Yancopoulos | President | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Name | Role | Address |
---|---|---|
Christopher Fenimore | Vice President | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Name | Role | Address |
---|---|---|
Robert Landry | Chief Financial Officer | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Name | Role | Address |
---|---|---|
Joseph J. LaRosa | Secretary | 777 Old Saw Mill River Road, Tarrytown, NY 10591 |
Type | Status | Filed Date | Description |
---|---|---|---|
Annual Report | Filed | 2024-04-01 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2023-02-08 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2022-03-14 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2021-04-05 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2020-04-09 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2019-04-04 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2018-03-29 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2017-03-14 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2016-03-16 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Annual Report | Filed | 2015-03-27 | Annual Report For Regeneron Pharmaceuticals, Inc. |
Date of last update: 25 Mar 2025
Sources: Mississippi Secretary of State